Breakthrough trial tests first medicine targeting Autism's core challenges
Disease control
Completed
This large, completed study tested whether a new medicine called AST-001 could improve the core social and behavioral challenges of autism in children. It involved 169 children in Korea and compared the medicine to a placebo. The goal was to see if this treatment could help where…
Phase: PHASE3 • Sponsor: Astrogen, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC